Vireo Growth (VREOF) Gross Margin (2020 - 2026)
Vireo Growth's (VREOF) quarterly Gross Margin came in at 55.84% in Q1 2026, up 523.0% year-on-year from 8.96% in Q1 2025, and up 2.59% quarter-over-quarter from 54.43% in Q4 2025.
Vireo Growth (VREOF) Gross Margin (2020 - 2026) Analysis & Trends
Vireo Growth has disclosed Gross Margin across 7 years of filings, most recently posting 55.84% for Q1 2026.
- Gross Margin for Q1 2026 came in at 55.84%, up 523.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 49.65% (down 138.0% YoY), and the FY2025 annual result was 47.29%, down 380.0% from the prior year.
- Gross Margin came in at 55.84% for Q1 2026 at Vireo Growth, up from 54.43% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 55.84% in Q1 2026 to a low of 15.91% in Q1 2022.
- The 5-year median for Gross Margin is 49.87% (2023), against an average of 47.55%.
- Across the five-year window, Gross Margin sank 2666 bps in 2022 and jumped 3396 bps in 2023, its largest moves.
- Vireo Growth's Gross Margin stood at 44.72% in 2022, then advanced by 12 bps to 49.87% in 2023, then increased by 1 bps to 50.56% in 2024, then climbed by 8 bps to 54.43% in 2025, then gained by 3 bps to 55.84% in 2026.
- The last three Gross Margin figures came in at 55.84% (Q1 2026), 54.43% (Q4 2025), and 40.79% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 49.52% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 71.66% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 82.93% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 49.50% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 98.31% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 57.26% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -293.83% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 65.25% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 61.20% |
| 10 | Vireo Growth | - | - | 59.30 Mn | 55.84% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 55.84% |
| Dec 31, 2025 | 54.43% |
| Sep 30, 2025 | 40.79% |
| Jun 30, 2025 | 42.48% |
| Mar 31, 2025 | 50.61% |
| Dec 31, 2024 | 50.56% |
| Sep 30, 2024 | 48.97% |
| Jun 30, 2024 | 53.97% |
| Mar 31, 2024 | 50.83% |
| Dec 31, 2023 | 49.87% |
| Sep 30, 2023 | 53.48% |
| Jun 30, 2023 | 46.20% |
| Mar 31, 2023 | 49.87% |
| Dec 31, 2022 | 44.72% |
| Sep 30, 2022 | 50.58% |
| Jun 30, 2022 | 49.16% |
| Mar 31, 2022 | 15.91% |
| Dec 31, 2021 | 15.78% |
| Sep 30, 2021 | 38.26% |
| Jun 30, 2021 | 48.58% |